King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Shaykhah Alotaibi
Dr. Shaykhah Alotaibi is a Consultant in Adult Hematology in Riyadh, Saudi Arabia, with clinical and research focus on acute leukaemia, CD19 CAR-T cell therapy, stem cell transplantation, and bone marrow failure syndromes. As a trusted hematology specialist in Riyadh, Saudi Arabia, she is co-author on landmark leading institutional research covering CAR-T cell therapy outcomes, TKIs in CML pregnancy, and long-term Fanconi anemia outcomes.Consultant in Adult Hematology, Stem Cell Transplantation & Cellular TherapyPatient recommendation rating 4.9/5 across 31+ reviewsCo-author on the 2024 ASH abstract on CD19 status in CAR-T for B-ALLCo-author on the 15-year single-centre study of TKIs in CML pregnancyActive in CAR-T, BMT, and inherited bone marrow failure clinical researchQualifications & Credentials
Medical Degrees
- MBBS (Bachelor of Medicine and Bachelor of Surgery)
- Internal Medicine Residency — Saudi Board
- Fellowship in Adult Hematology
Fellowships & Special Training
- Fellowship in Stem Cell Transplantation & Cellular Therapy
- Training in Acute Leukaemia and CAR-T Therapy
Certifications & Accreditations
- Saudi Commission for Health Specialties Registration
- Saudi Society of Hematology — Member
- American Society of Hematology (ASH) — Affiliation
Areas of Expertise
Major Conditions Treated
- Acute Lymphoblastic Leukaemia (ALL)
- Acute Myeloid Leukaemia (AML)
- Chronic Myeloid Leukaemia (CML)
- CML in Pregnancy
- Fanconi Anemia & Bone Marrow Failure
- Hodgkin & Non-Hodgkin Lymphoma
- Multiple Myeloma
- Stem Cell Transplant Candidacy
Sub-specialties
- Acute Leukaemia & Cellular Therapy: Specialist contribution to CAR-T cell therapy, allogeneic stem cell transplantation, and acute leukaemia management — a dedicated hematology specialist in Riyadh, Saudi Arabia.
- CML & Tyrosine Kinase Inhibitor Management: Active in landmark 15-year single-centre study on TKIs in pregnant CML patients.
- Inherited Bone Marrow Failure Syndromes: Co-author on long-term outcomes of Fanconi anemia in adult patients.
Advanced Procedures & Treatments
- Bone Marrow Aspiration & Biopsy
- Adult Hematology Consultation
- Chemotherapy Administration
- Tyrosine Kinase Inhibitor Therapy
- CD19 CAR-T Cell Therapy Management
- Allogeneic & Autologous Stem Cell Transplantation
Professional Experience
Current Affiliation
- Consultant, Adult Hematology — King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Member — Department of Hematology, Stem Cell Transplantation & Cellular Therapy
- Co-investigator — KFSHRC CAR-T, Fanconi Anemia, and CML-in-pregnancy research
Key Achievements
- Patient recommendation rating 4.9/5 across 31+ reviews
- Co-author on a 2024 ASH abstract on prognostic CD19 status in CAR-T for B-ALL
- Co-author on a 15-year single-centre study of TKIs in CML pregnancy (Blood 2024)
- Co-author on a 97-patient single-centre Fanconi anemia outcomes study (Blood 2022)
Awards & Recognitions
National & International Awards
- Information not publicly available for named awards.
Professional Memberships
- Saudi Society of Hematology
- American Society of Hematology (ASH) — Affiliation
- European Hematology Association (Affiliation)
Research & Publications
Published Papers (Selected)
- Alzaidy N, Mohammed Saleh MF, Abdrabou A, ... Alotaibi S, et al. Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia. Blood. 2024;144(Supplement 1):7153.
- Alzaidy N, Ben Lamine C, Sharif MI, ... Alotaibi S, et al. Evaluating the Safety and Efficacy of Tyrosine Kinase Inhibitors in Pregnant Patients with Chronic Myeloid Leukemia: A Comprehensive 15-Year Single-Center Study. Blood. 2024;144(Supplement 1):4536.
- Al-Sabbagh A, Alzahrani H, Dasouki MJ, ... Alotaibi S, et al. Clinical Characterization, Cancer Incidence and Long-Term Outcomes of Fanconi Anemia Patients: A Single Center Analysis of 97 Patients. Blood. 2022;140(Supplement 1):11471–11473.
Ongoing Research & Clinical Interests
- CD19 CAR-T cell therapy in B-ALL
- Tyrosine kinase inhibitors in CML pregnancy
- Long-term outcomes in Fanconi anemia
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Hematology Consultation | ₹1,500 – ₹3,500 | $18 – $42 |
| Bone Marrow Aspiration & Biopsy | ₹15,000 – ₹40,000 | $180 – $480 |
| Flow Cytometry Panel | ₹15,000 – ₹45,000 | $180 – $540 |
| Chemotherapy (per cycle, regimen-dependent) | ₹20,000 – ₹1,50,000 | $240 – $1,800 |
| Targeted Therapy (per month, drug-dependent) | ₹50,000 – ₹3,00,000 | $600 – $3,600 |
| Allogeneic Stem Cell Transplant | ₹15,00,000 – ₹30,00,000 | $18,000 – $36,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Shaykhah Alotaibi use in Adult Hematology treatment?
Dr. Shaykhah Alotaibi uses advanced hematology techniques including bone marrow aspiration and biopsy, chemotherapy and targeted therapy administration, tyrosine kinase inhibitor management, CD19 CAR-T cell therapy, and allogeneic and autologous stem cell transplantation. Virtual consultations and remote second opinions are available to international patients.
2. What conditions does Dr. Shaykhah Alotaibi specialize in treating?
Dr. Shaykhah Alotaibi specialises in acute lymphoblastic leukaemia, acute myeloid leukaemia, chronic myeloid leukaemia (including CML in pregnancy), Fanconi anemia and bone marrow failure, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and stem cell transplantation in Riyadh, Saudi Arabia.
3. How do I book an appointment with Dr. Shaykhah Alotaibi?
Appointments with Dr. Shaykhah Alotaibi can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Shaykhah Alotaibi?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Shaykhah Alotaibi, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counseling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Shaykhah Alotaibi offer second opinions for adult hematology cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert adult hematology specialist in Riyadh, Saudi Arabia.
